Use of pharmaceutical nanotechnology for the treatment of leishmaniasis

5Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects. Methods: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis. Results: Our findings revealed a stable number of patents and scientific articles published over the past five years. Conclusions: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.

Cite

CITATION STYLE

APA

Marques, C. S. F., Machado Júnior, J. B., Andrade, L. R. de M., Andrade, L. N., Dos Santos, A. L. S., E Cruz, M. D. S. P., … Severino, P. (2019). Use of pharmaceutical nanotechnology for the treatment of leishmaniasis. Revista Da Sociedade Brasileira de Medicina Tropical, 52. https://doi.org/10.1590/0037-8682-0246-2018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free